GH
Ghanshyam Himmatlal Morasiya
About Ghanshyam Himmatlal Morasiya
Data last updated:
Ghanshyam Himmatlal Morasiya is a Director at Upcare Pharma Private Limited (since 2019) and Director at Upharma R&D Private Limited (since 2026). The companies operate in Professional Services. The largest current company by reported revenue is Upcare Pharma Private Limited at ₹5.19 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Upcare Pharma Private Limited U74140GJ2019PTC110343 | Director | 16 Oct 2019 | 2019 | ₹5.19 Cr (FY 2025) | Active |
 Upharma R&D Private Limited U21002GJ2026PTC183495 | Director | 10 Sep 2026 | 2026 | Active |
Board colleagues of Ghanshyam Himmatlal Morasiya
| Name | DIN | Company | Designation |
|---|---|---|---|
| Himmatbhai Haribhai Morasiya | 08003401 | Upcare Pharma Private Limited | Director |
| Atef Azouz | 11939267 | Upharma R&D Private Limited | Director |
| Mohamed Gtari | 11939268 | Upharma R&D Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ghanshyam Himmatlal Morasiya
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ghanshyam Himmatlal Morasiya
Ghanshyam Himmatlal Morasiya currently holds 2 directorships: Upcare Pharma Private Limited (Director, since 16 Oct 2019, revenue ₹5.19 Cr (FY 2025)); Upharma R&D Private Limited (Director, since 10 Sep 2026).
Ghanshyam Himmatlal Morasiya was first appointed on 16 Oct 2019 as Director at Upcare Pharma Private Limited. The most recent appointment on record is 10 Sep 2026 at Upharma R&D Private Limited.
The current boards of Ghanshyam Himmatlal Morasiya's companies include Himmatbhai Haribhai Morasiya (Upcare Pharma Private Limited), Atef Azouz (Upharma R&D Private Limited), Mohamed Gtari (Upharma R&D Private Limited).